Genome Sequencing Helps Determine End of TB Outbreak
News Jun 15, 2016
The research is the first of its kind to demonstrate that genomic analysis can be used to determine when a TB outbreak has ended—valuable knowledge which can assist public health investigators understand an outbreak’s dynamics and guide a real-time public health response. Genomic analysis involves reading the complete genetic instructions of the pathogens causing a disease, and using that data to infer who might have infected whom. By looking for mutations that are shared between the pathogens taken from different people, researchers can see whose pathogens are most closely related to each other, suggesting potential transmission.
“Declaring the end of a TB outbreak is a difficult thing to do,” said senior author Jennifer Gardy, assistant professor in UBC’s school of population and public health and a senior scientist at the British Columbia Centre for Disease Control. “Because the bacterium that causes TB can lie dormant in someone’s lung for months or even years before it causes disease, we had no way of knowing whether a TB case we have just diagnosed was a recent infection – suggesting the outbreak is still going on – or whether the person was infected years ago.”
Using mathematical and statistical techniques, the researchers evaluated a TB outbreak that began in May 2008 and were able to determine when each outbreak case was infected. This provided public health officials with a way to determine when disease transmission had stopped and the outbreak had ended. They were able to declare the outbreak over in January 2015, after the data indicated no disease transmission had occurred since mid-2012.
“By using a series of techniques from the world of mathematics and statistics, we can come up with an estimated time at which each infection occurred,” explained Gardy. “This information is incredibly useful to the public health officials managing an outbreak. Responding to an outbreak requires a lot of effort and resources, and we need to know when we can step down our response.”
“Genomics has been used to monitor infectious disease outbreaks before, but this is the first time it’s ever been possible to declare a complicated outbreak of TB over,” said Gardy. “It really opens up new doors in the world of TB control.”
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.